Details for 2018820011

Up to date per 23.05.2026

Actions

Title / Product Name

DOSIERPARAMETER FÜR GEGEN CD47 GERICHTETE THERAPIEN FÜR HÄMATOLOGISCHE MALIGNOME

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018820011

EP Publication Number

3642242

E-Number

1655317

Language

PCT Number

US18038798

Publication Date

29.04.2020 A

07.02.2024 B1

Registration Date

07.02.2024

AT Publication Date

15.02.2024

Application Date

21.06.2018

Registration Number

Priorities

21.06.2017

201762523182 P

IPC

C07K 16/28 20060101AFI20210518BHEP

Maximum Duration of Protection

21.06.2038

Owner

The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

Forty Seven, LLC333 Lakeside Drive Foster City, CA 94404US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

MAJETI, Ravindra861 Newell Place Palo Alto California 94303US

CHAO, Mark P.2001 Showers Drive Mountain View California 94040US

LIU, Jie3119 Stockton Place Palo Alto California 94303US

VOLKMER, Jens-Peter752 Live Oak Avenue Apt. 4 Menlo Park California 94025US

WEISSMAN, Irving L.747 Santa Ynez Street Stanford California 94305US

Information about Fees